These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25798950)

  • 1. Hotspots in an obligate homodimeric anticancer target. Structural and functional effects of interfacial mutations in human thymidylate synthase.
    Salo-Ahen OM; Tochowicz A; Pozzi C; Cardinale D; Ferrari S; Boum Y; Mangani S; Stroud RM; Saxena P; Myllykallio H; Costi MP; Ponterini G; Wade RC
    J Med Chem; 2015 Apr; 58(8):3572-81. PubMed ID: 25798950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and Functional Characterization of the Human Thymidylate Synthase (hTS) Interface Variant R175C, New Perspectives for the Development of hTS Inhibitors.
    Pozzi C; Ferrari S; Luciani R; Costi MP; Mangani S
    Molecules; 2019 Apr; 24(7):. PubMed ID: 30959951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alanine mutants of the interface residues of human thymidylate synthase decode key features of the binding mode of allosteric anticancer peptides.
    Tochowicz A; Santucci M; Saxena P; Guaitoli G; Trande M; Finer-Moore J; Stroud RM; Costi MP
    J Med Chem; 2015 Jan; 58(2):1012-8. PubMed ID: 25427005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomolecular study of human thymidylate synthase conformer-selective inhibitors: New chemotherapeutic approach.
    El-Mesallamy HO; El Magdoub HM; Chapman JM; Hamdy NM; Schaalan MF; Hammad LN; Berger SH
    PLoS One; 2018; 13(3):e0193810. PubMed ID: 29538414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein-protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthase.
    Cardinale D; Guaitoli G; Tondi D; Luciani R; Henrich S; Salo-Ahen OM; Ferrari S; Marverti G; Guerrieri D; Ligabue A; Frassineti C; Pozzi C; Mangani S; Fessas D; Guerrini R; Ponterini G; Wade RC; Costi MP
    Proc Natl Acad Sci U S A; 2011 Aug; 108(34):E542-9. PubMed ID: 21795601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of Destabilization of the Human Thymidylate Synthase (hTS) Dimeric Structure Induced by the Interface Mutation Q62R.
    Pozzi C; Lopresti L; Santucci M; Costi MP; Mangani S
    Biomolecules; 2019 Apr; 9(4):. PubMed ID: 30987202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural analyses of human thymidylate synthase reveal a site that may control conformational switching between active and inactive states.
    Chen D; Jansson A; Sim D; Larsson A; Nordlund P
    J Biol Chem; 2017 Aug; 292(32):13449-13458. PubMed ID: 28634233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The active-inactive transition of human thymidylate synthase: targeted molecular dynamics simulations.
    Salo-Ahen OM; Wade RC
    Proteins; 2011 Oct; 79(10):2886-99. PubMed ID: 21905113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and characterization of a mutation outside the active site of human thymidylate synthase that affects ligand binding.
    Cardinale D; Salo-Ahen OM; Guaitoli G; Ferrari S; Venturelli A; Franchini S; Battini R; Ponterini G; Wade RC; Costi MP
    Protein Eng Des Sel; 2010 Feb; 23(2):81-9. PubMed ID: 19955218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Thymidylate Synthase Inhibitors Halting Ovarian Cancer Growth.
    Ferrari S; Severi L; Pozzi C; Quotadamo A; Ponterini G; Losi L; Marverti G; Costi MP
    Vitam Horm; 2018; 107():473-513. PubMed ID: 29544641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, characterization and molecular docking studies of thiouracil derivatives as potent thymidylate synthase inhibitors and potential anticancer agents.
    El-Naggar AM; Abou-El-Regal MM; El-Metwally SA; Sherbiny FF; Eissa IH
    Mol Divers; 2017 Nov; 21(4):967-983. PubMed ID: 28815411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational Propensity and Biological Studies of Proline Mutated LR Peptides Inhibiting Human Thymidylate Synthase and Ovarian Cancer Cell Growth.
    Saxena P; Severi L; Santucci M; Taddia L; Ferrari S; Luciani R; Marverti G; Marraccini C; Tondi D; Mor M; Scalvini L; Vitiello S; Losi L; Fonda S; Pacifico S; Guerrini R; D'Arca D; Ponterini G; Costi MP
    J Med Chem; 2018 Aug; 61(16):7374-7380. PubMed ID: 30035541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic Acid-Peptide Conjugates Combine Selective Cancer Cell Internalization with Thymidylate Synthase Dimer Interface Targeting.
    Marverti G; Marraccini C; Martello A; D'Arca D; Pacifico S; Guerrini R; Spyrakis F; Gozzi G; Lauriola A; Santucci M; Cannazza G; Tagliazucchi L; Cazzato AS; Losi L; Ferrari S; Ponterini G; Costi MP
    J Med Chem; 2021 Mar; 64(6):3204-3221. PubMed ID: 33710891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-targeted antifolates aimed at avoiding drug resistance form covalent closed inhibitory complexes with human and Escherichia coli thymidylate synthases.
    Sayre PH; Finer-Moore JS; Fritz TA; Biermann D; Gates SB; MacKellar WC; Patel VF; Stroud RM
    J Mol Biol; 2001 Nov; 313(4):813-29. PubMed ID: 11697906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic Peptides Acting as Allosteric Inhibitors of Human Thymidylate Synthase and Cancer Cell Growth.
    Pacifico S; Santucci M; Luciani R; Saxena P; Linciano P; Ponterini G; Lauriola A; D'Arca D; Marverti G; Guerrini R; Costi MP
    Molecules; 2019 Sep; 24(19):. PubMed ID: 31561530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dimer-monomer equilibrium of human thymidylate synthase monitored by fluorescence resonance energy transfer.
    Genovese F; Ferrari S; Guaitoli G; Caselli M; Costi MP; Ponterini G
    Protein Sci; 2010 May; 19(5):1023-30. PubMed ID: 20306493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-resistant variants of Escherichia coli thymidylate synthase: effects of substitutions at Pro-254.
    Fantz C; Shaw D; Jennings W; Forsthoefel A; Kitchens M; Phan J; Minor W; Lebioda L; Berger FG; Spencer HT
    Mol Pharmacol; 2000 Feb; 57(2):359-66. PubMed ID: 10648646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ligand binding and conformational switching on intracellular stability of human thymidylate synthase.
    Berger SH; Berger FG; Lebioda L
    Biochim Biophys Acta; 2004 Jan; 1696(1):15-22. PubMed ID: 14726200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Destabilizers of the thymidylate synthase homodimer accelerate its proteasomal degradation and inhibit cancer growth.
    Costantino L; Ferrari S; Santucci M; Salo-Ahen OMH; Carosati E; Franchini S; Lauriola A; Pozzi C; Trande M; Gozzi G; Saxena P; Cannazza G; Losi L; Cardinale D; Venturelli A; Quotadamo A; Linciano P; Tagliazucchi L; Moschella MG; Guerrini R; Pacifico S; Luciani R; Genovese F; Henrich S; Alboni S; Santarem N; da Silva Cordeiro A; Giovannetti E; Peters GJ; Pinton P; Rimessi A; Cruciani G; Stroud RM; Wade RC; Mangani S; Marverti G; D'Arca D; Ponterini G; Costi MP
    Elife; 2022 Dec; 11():. PubMed ID: 36475542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitor specificity via protein dynamics: insights from the design of antibacterial agents targeted against thymidylate synthase.
    Ferrari S; Costi PM; Wade RC
    Chem Biol; 2003 Dec; 10(12):1183-93. PubMed ID: 14700626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.